Immatics N.v. buy BiotechBee
Start price
07.09.22
/
60%
€13.10
Target price
31.12.24
€18.00
Performance (%)
-32.14%
End price
05.05.23
€8.89
Summary
This prediction ended on 05.05.23 with a price of €8.89. The BUY prediction by BiotechBee for Immatics N.v. performed very badly with a performance of -32.14%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Immatics N.v. | - | - | - |
iShares Core DAX® | 1.804% | -0.748% | 13.168% |
iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
iShares S&P 500 | 0.664% | -1.941% | 28.141% |
According to BiotechBee what are the pros and cons of Immatics N.v. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Immatics N.v. diskutieren
Buy mit Kursziel 18,0
In the thread Trading Immatics N.v.
Buy beendet